Results 241 to 250 of about 130,207 (296)
ABSTRACT Overweight and obesity are estimated to affect more than 40% of adults in the Asia‐Pacific (APAC) region. This study used a cross‐sectional online survey to assess the impact of obesity on health‐related quality of life (HRQOL) using the Impact of Weight on Quality of Life (IWQOL)‐Lite instrument and willingness to pay for obesity management ...
Hae‐Jin Ko +5 more
wiley +1 more source
Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review. [PDF]
Balkrishna A +10 more
europepmc +1 more source
Abstract Aims To evaluate the impact of obesity, with or without gestational diabetes mellitus (GDM), on adverse maternal outcomes and determine whether the combination of obesity and GDM confers a greater risk compared to obesity alone. Methods We systematically searched MEDLINE, EMBASE, Scopus, CINAHL and the WoS Core Collection, identifying 19 ...
Tessa L. Weir +2 more
wiley +1 more source
Next-generation Approaches in Targeting Polycystic Ovarian Syndrome: Innovative Strategies. [PDF]
Lakshmi Narayanan P +3 more
europepmc +1 more source
Abstract Aims This systematic review and meta‐analysis assessed the safety and efficacy of metformin in managing gestational diabetes mellitus (GDM), focusing on maternal, neonatal and long‐term outcomes. While lifestyle changes are first‐line treatment, pharmacological therapy is often required.
Mathilde Louise Saxdorff Brinkmann +7 more
wiley +1 more source
Psychological Distress and Fatigue in Polycystic Ovarian Syndrome: A Pilot Study. [PDF]
Bajpai A, Sharma D.
europepmc +1 more source
Abstract Aim CD4 + CD25highCD127‐T regulatory cells (Tregs) remain a drug candidate for immunotherapy of type 1 diabetes. We completed three trials testing Tregs in recently diagnosed type 1 diabetes children. Here, we looked for long‐term safety and efficacy aspects important in the authorisation of this therapy.
Marta Bandura +18 more
wiley +1 more source
Artificial intelligence in polycystic ovarian syndrome management: past, present, and future. [PDF]
Wang J +12 more
europepmc +1 more source
Abstract Aims To assess whether periconceptional exposure to glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) is associated with adverse outcomes in women with pregestational type 2 diabetes. Materials and Methods We linked Taiwan's Birth Certificate Application and National Health Insurance claims (2013–2022) to assemble a nationwide cohort of ...
Yi‐Chang Chou +5 more
wiley +1 more source

